Citations (19)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Ceryl A. Harwood, Kate Westgate, Sue Gunstone, Soren Brage, Nicholas J. Wareham, Christopher J. McDermott & Pamela J. Shaw. (2016) Long-term physical activity: an exogenous risk factor for sporadic amyotrophic lateral sclerosis?. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 17:5-6, pages 377-384.
Read now
Read now
Juyeon Oh, Ji Won An, Seong-Il Oh, Ki Wook Oh, Jung A Kim, Jeong Seop Lee & Seung Hyun Kim. (2015) Socioeconomic costs of amyotrophic lateral sclerosis according to staging system. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 16:3-4, pages 202-208.
Read now
Read now
Lindsay Rechtman, Heather Jordan, Laurie Wagner, D. Kevin Horton & Wendy Kaye. (2015) Racial and ethnic differences among amyotrophic lateral sclerosis cases in the United States. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 16:1-2, pages 65-71.
Read now
Read now
Articles from other publishers (16)
Flavia L. Lombardo, Stefania Spila Alegiani, Flavia Mayer, Marta Cipriani, Maria Lo Giudice, Albert Christian Ludolph, Christopher J. McDermott, Philippe Corcia, Philip Van Damme, Leonard H. Van den Berg, Orla Hardiman, Gabriele Nicolini, Nicola Vanacore, Brian Dickie, Alberto Albanese, Maria Puopolo, Paolo Tornese, Antoniangela Cocco, Michela Matteoli, Eliana Lauranzano, Maria Luisa Malosio, Chiara Adriana Elia, Adriano Chiò, Umberto Manera, Cristina Moglia, Andrea Calvo, Paolina Salamone, Giuseppe Fuda, Carlo Colosimo, Cristina Spera, Prabha Cristina Ranchicchio, Giuseppe Stipa, Domenico Frondizi, Christian Lunetta, Valeria Sansone, Claudia Tarlarini, Francesca Gerardi, Vincenzo Silani, Alberto Doretti, Eleonora Colombo, Gianluca Demirtzidis, Gioacchino Tedeschi, Francesca Trojsi, Carla Passaniti, Stefania Ballestrero, Johannes Dorst, Ulrike Weiland, Andrea Fromm, Maximilian Wiesenfarth, Katharina Kandler, Simon Witzel, Markus Otto, Joachim Schuster, Thomas Meyer, André Maier, Dagmar Kettemann, Susanne Petri, Lars Müschen, Camilla Wohnrade, Anastasia Sarikidi, Alma Osmanovic, Julian Grosskreutz, Annekathrin Rödiger, Robert Steinbach, Benjamin Ilse, Uta Smesny, Robert Untucht, René Günther, Maximilian Vidovic, Pamela Shaw, Alexis Collins, Helen Wollff, Theresa Walsh, Lee Tuddenham, Mbombe Kazoka, David White, Stacy Young, Benjamin Thompson, Daniel Madarshahian, Suresh K. Chhetri, Amina Chaouch, Carolyn A. Young, Heike Arndt, Coliver Hanemann, Thomas Lambert, Stephane Beltran, Philippe Couratier, Florence Esselin, William Camu, Elisa De La Cruz, Gwendal Lemasson, Pegah Masrori, Sinead Maguire, Liz Fogarty, Toyosi Atoyebi & Niamh Ní Obáin. (2023) A randomized double-blind clinical trial on safety and efficacy of tauroursodeoxycholic acid (TUDCA) as add-on treatment in patients affected by amyotrophic lateral sclerosis (ALS): the statistical analysis plan of TUDCA-ALS trial. Trials 24:1.
Crossref
Crossref
Theodore C. Larson, Stephen A. Goutman, Bryn Davis, Frank J. Bove, Neil Thakur & Paul Mehta. (2023)
Causes of death among United States decedents with
ALS
: An eye toward delaying mortality
. Annals of Clinical and Translational Neurology 10:5, pages 757-764.
Crossref
Crossref
Alberto Albanese, Albert Christian Ludolph, Christopher J. McDermott, Philippe Corcia, Philip Van Damme, Leonard H. Van den Berg, Orla Hardiman, Gilberto Rinaldi, Nicola Vanacore & Brian Dickie. (2022) Tauroursodeoxycholic acid in patients with amyotrophic lateral sclerosis: The TUDCA-ALS trial protocol. Frontiers in Neurology 13.
Crossref
Crossref
Andrea Vianello, Fabrizio Racca, Gian Luca Vita, Paola Pierucci & Giuseppe Vita. 2022. Respiratory Neurobiology: Physiology and Clinical Disorders, Part II. Respiratory Neurobiology: Physiology and Clinical Disorders, Part II
259
270
.
Tomomi Mitsuhata & Shinji Teramoto. 2020. Aspiration Pneumonia. Aspiration Pneumonia
3
13
.
Louise Rose, Douglas McKim, David Leasa, Mika Nonoyama, Anu Tandon, Yu Qing Bai, Reshma Amin, Sherri Katz, Roger Goldstein & Andrea Gershon. (2019) Trends in incidence, prevalence, and mortality of neuromuscular disease in Ontario, Canada: A population-based retrospective cohort study (2003-2014). PLOS ONE 14:3, pages e0210574.
Crossref
Crossref
Michael A van Es, Orla Hardiman, Adriano Chio, Ammar Al-Chalabi, R Jeroen Pasterkamp, Jan H Veldink & Leonard H van den Berg. (2017) Amyotrophic lateral sclerosis. The Lancet 390:10107, pages 2084-2098.
Crossref
Crossref
Christian Burkhardt, Christoph Neuwirth, Andreas Sommacal, Peter M. Andersen & Markus Weber. (2017) Is survival improved by the use of NIV and PEG in amyotrophic lateral sclerosis (ALS)? A post-mortem study of 80 ALS patients. PLOS ONE 12:5, pages e0177555.
Crossref
Crossref
Christopher A. Shaw. 2017. Neural Dynamics of Neurological Disease. Neural Dynamics of Neurological Disease
301
354
.
E.O. Talbott, A.M. Malek & D. Lacomis. 2016. Neuroepidemiology. Neuroepidemiology
225
238
.
Mark Laidlaw, Dominic Rowe, Andrew Ball & Howard Mielke. (2015) A Temporal Association between Accumulated Petrol (Gasoline) Lead Emissions and Motor Neuron Disease in Australia. International Journal of Environmental Research and Public Health 12:12, pages 16124-16135.
Crossref
Crossref
Marc G. Weisskopf, Merit E. Cudkowicz & Norman Johnson. (2015) Military Service and Amyotrophic Lateral Sclerosis in a Population-based Cohort. Epidemiology 26:6, pages 831-838.
Crossref
Crossref
Susan T. Paulukonis, Eric M. Roberts, Jhaqueline P. Valle, Natalie N. Collins, Paul B. English & Wendy E. Kaye. (2015) Survival and Cause of Death among a Cohort of Confirmed Amyotrophic Lateral Sclerosis Cases. PLOS ONE 10:7, pages e0131965.
Crossref
Crossref
Yun Kyung Hahn, Elizabeth M. Podhaizer, Sean P. Farris, Michael F. Miles, Kurt F. Hauser & Pamela E. Knapp. (2013) Effects of chronic HIV-1 Tat exposure in the CNS: heightened vulnerability of males versus females to changes in cell numbers, synaptic integrity, and behavior. Brain Structure and Function 220:2, pages 605-623.
Crossref
Crossref
Ammar Al-Chalabi & Orla Hardiman. (2013) The epidemiology of ALS: a conspiracy of genes, environment and time. Nature Reviews Neurology 9:11, pages 617-628.
Crossref
Crossref
. (2014) A Real-World Glimpse into the Epidemiology of ALS in Canada. Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques 40:5, pages 625-625.
Crossref
Crossref